Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile

被引:7
|
作者
Brebi, Priscilla [1 ,2 ]
Gloria Ili, Carmen [1 ,2 ]
Andana, Alejandra [1 ,2 ]
Menzel, Doris [1 ,2 ]
Lopez, Jaime [1 ,2 ]
Guzman, Pablo [1 ]
Melo, Angelica [2 ]
Buchegger, Kurt [1 ,2 ]
Roa, Juan C. [3 ,4 ]
机构
[1] Univ La Frontera, Fac Med, Dept Anat Patol, Lab Patol Mol, Casilla 54-D, Temuco, Chile
[2] Univ La Frontera, Ctr Excelencia Med Traslac Sci & Technol Bioresou, Casilla 54-D, Temuco, Chile
[3] Pontificia Univ Catolica Chile, Sch Med, Dept Pathol, Marcoleta 377,7th Floor, Santiago, Chile
[4] Millennium Inst Immunol & Immunotherapy P09 016 F, Adv Ctr Chron Dis ACCDiS, Santiago, Chile
关键词
Human papillomavirus; Cervical intraepithelial neoplasia; Cervical cancer; Polymerase chain reaction; Reverse line blotting assay; HYBRID-CAPTURE-II; HPV TYPES; NATURAL-HISTORY; VIRUS; PREVALENCE; LESIONS; IDENTIFICATION; EPIDEMIOLOGY; WORLDWIDE; INFECTION;
D O I
10.1186/s12885-017-3496-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Human papillomavirus (HPV) is the etiological factor for cervical cancer and its precursor lesions. The characterization of HPV genotypes in preneoplastic lesions and cervical cancer could establishes the effectiveness of vaccination plan in Chilean population. The aim of this study was to determine HPV frequency in a group of women including in a cervical screening program in the public health care system in Chile. Methods: We analyzed 985 cervical smears samples from women with different histological diagnosis, attending to public health care in Temuco-Chile between 2004 and 2012, to detect HPV genotypes, through PCR followed by reverse line blotting assay. Results: HPV was found present in 80.8% (n = 796) of samples. Only a 5.6% of 985 samples were infected with a low-risk HPV, considering multiple infections. 10.5% (n = 8/76) of normal cervical epithelia, 83.5% (n = 208/249) and 87.6% (n = 557/636) of low and high grade squamous intraepithelial lesions, respectively, and 95.8% (n = 23/24) of squamous cervical carcinomas tested positive for HPV. HPV 16 was the most frequent genotype found (Overall 44.9%, n = 442/985; SCC: 62.5%, n = 15/24). A high variability of HPV types was also found in preneoplastic lesions, whereas there was a selection of genotypes in neoplasia. Also, there was a higher risk of infection with HPV 16 in women <= 26 years and 34-41 years old (p < 0.05), meanwhile infections with HPV 16 or HPV 18 have related with cancer development (p < 0.01). Conclusions: These data provide further information about the frequency of HPV genotypes in women with cervical lesions in Chile, and the introduction of new targeted vaccines against a wider spectrum of HPV is suggested.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] PARTICIPATION IN CERVICAL CANCER SCREENING AND KNOWLEDGE ON HUMAN PAPILLOMAVIRUS AMONG WOMEN IN VAC, HUNGARY
    Vajda, R.
    Miskolczi, A.
    Kives, Horvathne Z.
    Pakai, A.
    Gyuro, M.
    Molics, B.
    Csakvari, T.
    Repasy, B.
    Danku, N.
    Boncz, I
    VALUE IN HEALTH, 2015, 18 (03) : A209 - A209
  • [42] Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening
    Tota, Joseph E.
    Bentley, James
    Blake, Jennifer
    Coutlee, Francois
    Duggan, Maire A.
    Ferenczy, Alex
    Franco, Eduardo L.
    Fung-Kee-Fung, Michael
    Gotlieb, Walter
    Mayrand, Marie-Helene
    McLachlin, Meg
    Murphy, Joan
    Ogilvie, Gina
    Ratnam, Sam
    PREVENTIVE MEDICINE, 2017, 98 : 15 - 20
  • [43] Women's intentions to receive cervical cancer screening with primary human papillomavirus testing
    Ogilvie, Gina S.
    Smith, Laurie W.
    van Niekerk, Dirk J.
    Khurshed, Fareeza
    Krajden, Mel
    Saraiya, Mona
    Goel, Vivek
    Rimer, Barbara K.
    Greene, Sandra B.
    Hobbs, Suzanne
    Coldman, Andrew J.
    Franco, Eduardo L.
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (12) : 2934 - 2943
  • [44] Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women
    Huang, Alison J.
    Perez-Stable, Eliseo J.
    Kim, Sue E.
    Wong, Sabrina T.
    Kaplan, Celia P.
    Walsh, Judith M. E.
    Iwaoka-Scott, A. Yuri
    Sawaya, George F.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 (09) : 1324 - 1329
  • [45] Knowledge of Human Papillomavirus, Risk Factors and Screening for Cervical Cancer Among Women in Ghana
    Nartey, Yvonne
    Amo-Antwi, Kwabena
    Osei-Ntiamoah, Betty
    Hill, Philip C.
    Dassah, Edward T.
    Asmah, Richard H.
    Nyarko, Kofi M.
    Agambire, Ramatu
    Konney, Thomas O.
    Yarney, Joel
    Damale, Nelson
    Cox, Brian
    CANCER CONTROL, 2025, 32
  • [46] Risk of human papillomavirus infection in women with rheumatic disease: cervical cancer screening and prevention
    Kim, Seoyoung C.
    Feldman, Sarah
    Moscicki, Anna-Barbara
    RHEUMATOLOGY, 2018, 57 : V26 - V33
  • [47] HUMAN PAPILLOMAVIRUS INFECTION IN WOMEN ATTENDED AT A CERVICAL CANCER SCREENING SERVICE IN NATAL, BRAZIL
    de Medeiros Fernandes, Thales Allyrio Araujo
    Meissner, Rosely de Vasconcellos
    Bezerra, Laelson Freire
    Medeiros de Azevedo, Paulo Roberto
    Fernandes, Jose Verissimo
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2008, 39 (03) : 573 - 578
  • [48] Human papillomavirus testing for primary cervical cancer screening
    Meijer, CJLM
    Rozendaal, L
    vanderLinden, JC
    Helmerhorst, TJM
    Voorhorst, FJ
    Walboomers, JMM
    NEW DEVELOPMENTS IN CERVICAL CANCER SCREENING AND PREVENTION, 1997, : 338 - 347
  • [49] Human papillomavirus testing as a screening tool for cervical cancer
    Koss, LG
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (19): : 2525 - 2525
  • [50] Role of human papillomavirus genotyping in cervical cancer screening
    Andujar-Sanchez, Miguel
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2023, 41 (05): : 259 - 261